Coates, L., Rahman, P., Mease, P., Shawi, M., Rampakakis, E., Kollmeier, A., . . . Tam, L. (2024). Continuous improvement through differential trajectories of individual minimal disease activity criteria with guselkumab in active psoriatic arthritis: Post hoc analysis of a phase 3, randomized, double-blind, placebo-controlled study. BioMed Central.
Cita Chicago Style (17a ed.)Coates, LC, et al. Continuous Improvement Through Differential Trajectories of Individual Minimal Disease Activity Criteria with Guselkumab in Active Psoriatic Arthritis: Post Hoc Analysis of a Phase 3, Randomized, Double-blind, Placebo-controlled Study. BioMed Central, 2024.
Cita MLA (9a ed.)Coates, LC, et al. Continuous Improvement Through Differential Trajectories of Individual Minimal Disease Activity Criteria with Guselkumab in Active Psoriatic Arthritis: Post Hoc Analysis of a Phase 3, Randomized, Double-blind, Placebo-controlled Study. BioMed Central, 2024.